Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Henric Jan Blok"'
Autor:
Rafal Machowicz, Felipe Suarez, Wieslaw Wiktor-Jedrzejczak, Diderik-Jan Eikema, Liesbeth C. de Wreede, Henric-Jan Blok, Cecilia Isaksson, Hermann Einsele, Xavier Poiré, Suzanne van Dorp, Emmanouil Nikolousis, Jan-Erik Johansson, Guido Kobbe, Marco Zecca, Renate Arnold, Armin Gerbitz, Jürgen Finke, Jose Luis Díez-Martín, Francesca Bonifazi, Grant McQuaker, Stig Lenhoff, Pierre-Simon Rohrlich, Matthias Theobald, Per Ljungman, Matthew Collin, Michael H. Albert, Gerhard Ehninger, Kristina Carlson, Kazimierz Halaburda, Kai Lehmberg, Stefan Schönland, Ibrahim Yakoub-Agha, Andrew R. Gennery, Arjan C. Lankester, Nicolaus Kröger
Publikováno v:
Bone Marrow Transplantation, 57, 817-823
Bone Marrow Transplantation, 57, 5, pp. 817-823
Bone marrow transplantation, Vol. 57, no.5, p. 817-823 (2022)
Bone Marrow Transplantation, 57(5), 817-823. SPRINGERNATURE
Bone Marrow Transplantation, 57, 5, pp. 817-823
Bone marrow transplantation, Vol. 57, no.5, p. 817-823 (2022)
Bone Marrow Transplantation, 57(5), 817-823. SPRINGERNATURE
Contains fulltext : 251601.pdf (Publisher’s version ) (Closed access) Hemophagocytic lymphohistiocytosis (HLH; hemophagocytic syndrome) is a rare syndrome of potentially fatal, uncontrolled hyperinflammation. Allogeneic hematopoietic stem cell tran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52ca36979ab7d9797f0ed370a17a4405
https://doi.org/10.1038/s41409-022-01634-5
https://doi.org/10.1038/s41409-022-01634-5
Autor:
Mahmoud Aljurf, Paul Browne, Simona Iacobelli, Marie Robin, Jennifer Hoek, Péter Reményi, Nicolaus Kroeger, John A. Snowden, Ibrahim Yakoub Agha, Henrik Sengeloev, Elena V. Morozova, Henric-Jan Blok, Yves Chalandon, Arnold Ganser, Arnon Nagler, Grzegorz Helbig, Riitta Niittyvuopio, Hélène Labussière Wallet, Eduardo Olavarria, Patrick Hayden, Stavroula Masouridi-Levrat, Theo de Witte, Jakob Passweg, Gwendolyn Van Gorkom
Publikováno v:
Bone Marrow Transplantation, 57(1), 23-30. Nature Publishing Group
Masouridi-Levrat, S, Olavarria, E, Iacobelli, S, Aljurf, M, Morozova, E, Niittyvuopio, R, Sengeloev, H, Reményi, P, Helbig, G, Browne, P, Ganser, A, Nagler, A, Snowden, J A, Robin, M, Passweg, J, Van Gorkom, G, Wallet, H L, Hoek, J, Blok, H J, De Witte, T, Kroeger, N, Hayden, P, Chalandon, Y & Agha, I Y 2022, ' Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors : a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT ', Bone Marrow Transplantation, vol. 57, no. 1, pp. 23-30 . https://doi.org/10.1038/s41409-021-01472-x
Bone marrow transplantation, Vol. 57, No 1 (2022) pp. 23-30
Bone Marrow Transplantation
Bone Marrow Transplantation, 57, 1, pp. 23-30
Bone Marrow Transplantation, 57, 23-30
Masouridi-Levrat, S, Olavarria, E, Iacobelli, S, Aljurf, M, Morozova, E, Niittyvuopio, R, Sengeloev, H, Reményi, P, Helbig, G, Browne, P, Ganser, A, Nagler, A, Snowden, J A, Robin, M, Passweg, J, Van Gorkom, G, Wallet, H L, Hoek, J, Blok, H J, De Witte, T, Kroeger, N, Hayden, P, Chalandon, Y & Agha, I Y 2022, ' Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors : a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT ', Bone Marrow Transplantation, vol. 57, no. 1, pp. 23-30 . https://doi.org/10.1038/s41409-021-01472-x
Bone marrow transplantation, Vol. 57, No 1 (2022) pp. 23-30
Bone Marrow Transplantation
Bone Marrow Transplantation, 57, 1, pp. 23-30
Bone Marrow Transplantation, 57, 23-30
Contains fulltext : 248798.pdf (Publisher’s version ) (Open Access) Allogeneic hematopoietic cell transplantation (allo-HCT) remains a treatment option for patients with chronic myeloid leukemia (CML) who fail to respond to tyrosine kinase inhibito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff78e844b861cf75faadfac5cf13700c
https://cris.maastrichtuniversity.nl/en/publications/4eab7206-4d79-4109-9ce6-4da16dcc7250
https://cris.maastrichtuniversity.nl/en/publications/4eab7206-4d79-4109-9ce6-4da16dcc7250
Autor:
Mutlu Arat, Jenny Byrne, Ibrahim Yakoub-Agha, Sascha Dietrich, Johanna Tischer, Federica Sorà, Nicolaas Schaap, Eleni Tholouli, Francis Ayuk, Joan Hendrik Veelken, Yves Chalandon, Yener Koc, Henric Jan Blok, Johan Maertens, Per Ljungman, Maija Itälä-Remes, Jürgen Finke, Pavel Jindra, Jiri Mayer, Michael Stadler, Gérard Socié, Vanderson Rocha, Jakob Passweg, Arnon Nagler, Nicolaus Kröger, Aleksandar Radujkovic
Publikováno v:
Biology of Blood and Marrow Transplantation, 25, 10, pp. 2008-2016
Biology of Blood and Marrow Transplantation, Vol. 25, No 10 (2019) pp. 2008-2016
Biology of Blood and Marrow Transplantation
Biology of Blood and Marrow Transplantation, 25, 2008-2016
Biology of Blood and Marrow Transplantation, 25(10), 2008-2016. ELSEVIER SCIENCE INC
Biology of Blood and Marrow Transplantation, Vol. 25, No 10 (2019) pp. 2008-2016
Biology of Blood and Marrow Transplantation
Biology of Blood and Marrow Transplantation, 25, 2008-2016
Biology of Blood and Marrow Transplantation, 25(10), 2008-2016. ELSEVIER SCIENCE INC
The prognosis of patients with blast crisis (BC) chronic myeloid leukemia (CML) is still dismal. Allogeneic stem cell transplantation represents the only curative treatment option, but data on transplant outcomes are scarce. We therefore conducted a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e08f770d74a43c0850237d3c99324464
https://doi.org/10.1016/j.bbmt.2019.06.028
https://doi.org/10.1016/j.bbmt.2019.06.028
Autor:
Petr Sedlacek, Susanne Matthes, Polina Stepensky, Caroline A. Lindemans, Junfeng Wang, Jolanta Gozdzik, Manfred Hoenig, Krzysztof Kałwak, Juliana F Fernandes, Su Han Lum, Brigitte Strahm, Matthias Felber, Bénédicte Neven, Arjan C. Lankester, Amal Al Seraihy, Mervi Taskinen, Ansgar Schulz, Tayfun Güngör, Franco Locatelli, Andrew R. Gennery, Mathias Hauri-Hohl, Giovanna Lucchini, Michael H. Albert, Sheree Hazelaar, Despina Moshous, Robert Wynn, Fulvio Porta, Henric Jan Blok, Brenda Gibson, Marco Zecca, Paul Veys, Fabian Hauck, Per Ljungman, Urs Schanz, Dmitry Balashov, Serap Aksoylar, Robert Chiesa, Karl Walter Sykora, Musa Karakukcu, Mary Slatter
Publikováno v:
Blood, 136(10), 1201-1211. AMER SOC HEMATOLOGY
Chronic granulomatous disease (CGD) is a primary immunodeficiency resulting in life-threatening infections and inflammatory complications. Allogeneic hematopoietic cell transplantation (allo-HCT) can cure the disease, but the indication to transplant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbc3dc7a0020fc1644f2e73747ec8ba2
http://hdl.handle.net/1887/3184828
http://hdl.handle.net/1887/3184828
Autor:
Vanderson Rocha, Johanna Tischer, Arnold Ganser, Mutlu Arat, Federica Sorà, Henric-Jan Blok, Koc Yener, Arnon Nagler, Gérard Socié, Pavel Jindra, Jakob Passweg, Jennifer Byrne, Aleksandar Radujkovic, Nicolaas Schaap, Yves Chalandon, Jiri Mayer, Per Ljungman, Maija Itälä-Remes, Eleni Tholouli, Jürgen Finke, Hendrik Veelken, Francis Ayuk, Johan Maertens, Kroger Nicolaus
Introduction: The prognosis of patients diagnosed with blast crisis (BC) chronic myeloid leukemia (CML) is dismal. Allogeneic stem cell transplantation (alloSCT) represents the only curative treatment option. In the current tyrosine kinase inhibitor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fe4169c411c90c3d8a3194d0102406b
https://hdl.handle.net/1887/122177
https://hdl.handle.net/1887/122177
Autor:
Jolanta Gozdzik, Caroline A. Lindemans, Urs Schanz, Manfred Hoenig, Karl-Walter Sykora, Robert Chiesa, Benedicte Neven, Petr Sedlacek, Franco Locatelli, Henric-Jan Blok, Mary Slatter, Polina Stepensky, Michael H. Albert, Ansgar Schulz, Matthias Felber, Amal Al-Seraihy, Serap Aksoylar, Krzysztof Kałwak, Arjan C. Lankester, Marco Zecca, Andrew R. Gennery, Brigitte Strahm, Paul Veys, Fabian Hauck, Per Ljungman, Robert Wynn, Su Han Lum, Despina Moshous, Junfeng Wang, Tayfun Guengoer
Publikováno v:
Blood, 132
Introduction: Chronic granulomatous disease (CGD) is a rare primary immunodeficiency disease characterized by impairment of the phagocyte NADPH-oxidase complex, resulting in deficient microbial killing and life-threatening bacterial and fungal infect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c523b2aef2ca2c0a96f9094e3334e298
http://hdl.handle.net/1887/3195443
http://hdl.handle.net/1887/3195443
Autor:
Andrew R. Gennery, Marc Bierings, Christopher C. Dvorak, W. Scott Goebel, Mirjam E. Belderbos, Rebecca H. Buckley, Morton J. Cowan, Juliana M.F. Silva, E. Richard Stiehm, Caroline Y. Kuo, Bénédicte Neven, Henric Jan Blok, Dirk Jan Eikema, Theresa Cole, Paul Veys, Robert Wynn, Manfred Hoenig
Publikováno v:
Journal of Allergy and Clinical Immunology, 142(5), 1628. Mosby Inc.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a494fc7c9afb34928708bb1e512c6891
https://europepmc.org/articles/PMC6226332/
https://europepmc.org/articles/PMC6226332/
Autor:
Michael H. Albert, Nicolaus Kröger, Manos Nikolousis, J. L. Diez-Martin, Kristina Carlson, Henric-Jan Blok, Liesbeth C. de Wreede, Herman Einsele, Guido Kobbe, Rafal Machowcz, Diderik-Jan Eikema, Grant McQuacker, Pierre-Simon Rohrlich, Xavier Poiré, Nicolaas Schaap, Per Ljungman, Stig Lenhoff, Matthew Collin, Kai Lehmberg, Marco Zecca, Jan-Erik Johansson, Francesca Bonifazi, Felipe Suarez, Stefan Schoenland, Arjan C. Lankester, Kazimierz Hałaburda, Matthias Theobald, Cecilia Isaksson, Renate Arnold, Andrew R. Gennery, Wieslaw Wiktor-Jedrzejczak, Gerhard Ehninger, Juergen Finke
Publikováno v:
Pediatric Blood & Cancer. 64:e26770
Allogeneic Hematopoietic Stem Cell Transplantation Provides Cure for Adult Patients with Hemophagocytic Lymphohistiocytosis (HLH) : A Retrospective Study of The Chronic Malignancies and Inborn ErrorsWorking Parties (CMWP and IEWP) of The EBMT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58b3fc8b043068227e5d87c1c98a7dd7
https://doi.org/10.1002/pbc.26770
https://doi.org/10.1002/pbc.26770
Autor:
Joerg Thomas Bittenbring, Dietrich W. Beelen, Henric-Jan Blok, Carol Moreno, Dominik Selleslag, Carlos Solano, Paolo Corradini, Luca Castagna, Patrice Chevallier, Nicolaus Kröger, Roberto Foa, Gwendolyn Van Gorkom, Michel van Gelder, Michael Hallek, Johanna Tischer, Fabio Ciceri, Lutz P. Müller, Yener Koc, Matthias Theobald, Dimitris Ziagkos, Inken Hilgendorf, Maria Teresa Van Lint, Johannes Schetelig, Didier Blaise
Publikováno v:
Blood. 128:3504-3504
Introduction: Allogeneic hematopoietic stem cell transplantation (HCT) is a treatment for CLL that can give long disease control. Even with the availability of kinase and BCL2 inhibitors, HCT is still performed in fit patients (pts) with high-risk CL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::874859897d1d067c1854bce74b86ae3c
https://doi.org/10.1182/blood.v128.22.3504.3504
https://doi.org/10.1182/blood.v128.22.3504.3504
Autor:
Liisa Volin, Jennifer Hoek, Slawomira Kyrcz-Krzemien, Arnold Ganser, Mahmoud Aljurf, Henric-Jan Blok, Theo de Witte, Henrik Sengeloev, Arnon Nagler, Eduardo Olavarria, Paul Browne, Mauricette Michallet, Simona Iacobelli, Yves Chalandon, Michael Schleuning, Nicolaus Kröger, Harry C. Schouten, Jakob Passweg, Carmino de Sousa, John A. Snowden, Boris V. Afanasyev, Tamas Masszi, Gérard Socié
Publikováno v:
Blood. 128:628-628
Introduction: Allogeneic stem cell transplantation (SCT) remains a treatment option for patients with chronic myeloid leukemia (CML) that fail to respond to tyrosine kinase inhibitors (TKI). While the use of Imatinib seems to have no adverse impact o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51ea3ed26afd14d951d82c62e7b8463f
https://doi.org/10.1182/blood.v128.22.628.628
https://doi.org/10.1182/blood.v128.22.628.628